WBI Investments LLC Takes Position in Invesco Pharmaceuticals ETF $PJP

WBI Investments LLC acquired a new stake in Invesco Pharmaceuticals ETF (NYSEARCA:PJP) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 5,395 shares of the company’s stock, valued at approximately $499,000. WBI Investments LLC owned 0.19% of Invesco Pharmaceuticals ETF as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in PJP. AE Wealth Management LLC lifted its position in shares of Invesco Pharmaceuticals ETF by 21.5% during the 2nd quarter. AE Wealth Management LLC now owns 717 shares of the company’s stock valued at $57,000 after acquiring an additional 127 shares during the period. Jones Financial Companies Lllp grew its holdings in shares of Invesco Pharmaceuticals ETF by 11.6% in the 1st quarter. Jones Financial Companies Lllp now owns 2,428 shares of the company’s stock worth $210,000 after acquiring an additional 252 shares during the period. Northwestern Mutual Wealth Management Co. increased its stake in Invesco Pharmaceuticals ETF by 5.7% in the 3rd quarter. Northwestern Mutual Wealth Management Co. now owns 2,791 shares of the company’s stock valued at $258,000 after purchasing an additional 150 shares in the last quarter. Tower Research Capital LLC TRC increased its stake in Invesco Pharmaceuticals ETF by 102.9% in the 2nd quarter. Tower Research Capital LLC TRC now owns 4,680 shares of the company’s stock valued at $374,000 after purchasing an additional 2,374 shares in the last quarter. Finally, Citadel Advisors LLC acquired a new position in Invesco Pharmaceuticals ETF during the third quarter worth $504,000.

Invesco Pharmaceuticals ETF Stock Performance

PJP opened at $101.56 on Thursday. The company has a market cap of $387.96 million, a price-to-earnings ratio of 15.59 and a beta of 0.50. Invesco Pharmaceuticals ETF has a one year low of $72.25 and a one year high of $110.81. The business’s fifty day moving average is $106.59 and its two-hundred day moving average is $101.61.

About Invesco Pharmaceuticals ETF

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.